financetom
Business
financetom
/
Business
/
Morguard North American Residential REIT Reports a Third-Quarter Loss
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Morguard North American Residential REIT Reports a Third-Quarter Loss
Nov 3, 2024 2:24 PM

04:31 PM EDT, 10/29/2024 (MT Newswires) -- Morguard North American Residential REIT (MRC.TO, MRG-UN.TO) reported after close Tuesday a third quarter loss due to fair-value charges.

The REIT said it lost of $18.8 million for the three months ended Sept. 30, a drop of of $58 million compared to 2023, predominantly due to a higher net fair value loss and an increase in deferred income tax.

The REIT said its net operating income was $52 million, down $400,000 from the year-prior quarter.

Funds from operations were $21.9 million, or $0.40 per unit, down by $0.1 million.

Th REIT's units closed down $0.01 to $18.65 on the Toronto Stock Exchange.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Maia Biotechnology, Regeneron Expand Clinical Supply Deal
Maia Biotechnology, Regeneron Expand Clinical Supply Deal
Dec 3, 2024
09:19 AM EST, 12/03/2024 (MT Newswires) -- Maia Biotechnology ( MAIA ) said Tuesday that it has amended a 2021 clinical supply deal with Regeneron (REGN) to cover the expansion of a phase 2 clinical trial evaluating investigational drug THIO in non-small cell lung cancer. According to the terms of the amended clinical supply agreement, Maia said Regeneron will provide...
Haemonetics to Sell Whole Blood Assets to GVS for $67.1 Million
Haemonetics to Sell Whole Blood Assets to GVS for $67.1 Million
Dec 3, 2024
09:21 AM EST, 12/03/2024 (MT Newswires) -- Haemonetics ( HAE ) said Tuesday it had agreed to sell its whole blood assets to GVS, an Italy-based manufacturer of filter solutions for the healthcare and life sciences sectors. The transaction is valued at up to $67.1 million, including an upfront payment of $44.6 million and contingent earn-outs of up to $22.5...
Exclusive-Intel's CEO-shortlist candidates include former board member Lip-Bu Tan, sources say
Exclusive-Intel's CEO-shortlist candidates include former board member Lip-Bu Tan, sources say
Dec 3, 2024
(Reuters) - Intel ( INTC ) has started shortlisting a handful of candidates, including former board member Lip-Bu Tan, for the role of chief executive after the struggling American chipmaker ousted company veteran Pat Gelsinger, according to people familiar with the matter.  Tan, who was once seen as a contender for the CEO role, has in recent days been approached by...
AT&T Revises 2024 Guidance, Targets $22 Billion Annual Capital Investment Through 2027 & More
AT&T Revises 2024 Guidance, Targets $22 Billion Annual Capital Investment Through 2027 & More
Dec 3, 2024
AT&T Inc. ( T ) shares are trading higher after the company updated its 2024 guidance and disclosed its long-term strategy. Strategy Update: AT&T ( T ) is modernizing its 5G wireless network, aiming to complete the transition to open, high-capacity technology by 2027. The network, with deep mid-band 5G spectrum, will cover over 300 million people by the end...
Copyright 2023-2026 - www.financetom.com All Rights Reserved